InvestorsHub Logo
Followers 13
Posts 1242
Boards Moderated 0
Alias Born 12/29/2010

Re: None

Monday, 10/23/2017 12:32:07 PM

Monday, October 23, 2017 12:32:07 PM

Post# of 54983
New recomendation could be moving price today.


Today, I'm going to bring a company to your attention that I think fits that model. When I was thinking about how to introduce this company to all of you, it reminded me of one of the funniest movies I think I've ever seen, Goldmember - starring the infamous Austin Powers.

If you've seen the movie then you know it's littered with so many one liners it's ridiculous. The clip I'm referring to though is when Dr. Evil offers up a series of questions: Would you like a smoke and a pancake? You know, flapjack and a cigarette? No? All right. Cigar and a waffle? No? Pipe and a crepe? No? Bong and a blintz? No? Oh, well, then there is no pleasing you.

I know pretty stupid, right? Well, today's new idea isn't stupid at all. At least not in my opinion anyway.



22nd Century Group, Inc. (XXII) focuses on the research, development, licensing, manufacturing, and worldwide sales and distribution of some pretty important products. The company's proprietary genetic engineering technology and plant breeding expertise allow them to regulate the level of nicotine (and other nicotinic alkaloids) in the tobacco plant. As a result of this technology, the company is able to grow tobacco with up to 97% less nicotine than conventional tobacco - as well as plants with relatively high nicotine levels.

The applications for this technology are extraordinary; in independent clinical studies, the company's very low nicotine (VLN) tobacco has demonstrated remarkable efficacy as a smoking cessation aid. On the other hand, for smokers who do not wish to quit, high nicotine tobacco enables the company to produce a cigarette with what they believe will end up being the world's lowest tar-to-nicotine ratio.

The tobacco industry is at the beginning of a paradigm shift toward the development and commercialization of reduced-risk tobacco products which represent a significant step toward achieving the public health objective of harm reduction. The company's 18 years of research and development on the tobacco plant, mainly on the nicotine biosynthetic pathway, has uniquely positioned them to become a major benefactor of this paradigm shift developing in the tobacco industry.

Its technology has created, and will continue to develop, a pipeline of products primarily involved in the following activities:

The international licensing of 22nd Century Ltd's technology, proprietary tobaccos, and trademarks
The research and development of potentially reduced-risk or modified risk tobacco products
The development of X-22, a prescription-based smoking cessation aid consisting of very low nicotine cigarettes
The manufacture, marketing and international distribution of RED SUN and MAGIC proprietary cigarettes
The production of SPECTRUM research cigarettes for the National Institute of Drug Abuse (NIDA)
The contract manufacturing of other companies' branded tobacco products
The company has had a pretty nice sequence of news events over the last several months, which you can view by going here: https://ir.xxiicentury.com/press-releases.

Like any other small stock, 22nd Century Group, Inc. (XXII) doesn't come without a fair amount of risk. But, the company has managed to produce about $12 million in revenue over the last 12 months, still has about $12 million in cash in the bank, and insiders must believe in what they're doing, because they still own about 16% of the deal.

Not bad for a stock that trades around $2.80 per share. You don't see that too often, and if the way the stock has been acting is any indication of what's to come, speculative investors might want to consider owning a piece of it.



You just have to be prepared to deal with the ups and the downs of a small stock like 22nd Century Group, Inc. (XXII). For those out there though who understand the importance of a company needing to be disruptive within its industry vertical to end up providing home-run potential, it sure looks like XXII could be one to pay close attention to.

Warmest regards,
SmallCap Network
www.smallcapnetwork.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News